Adage Capital Partners Gp, L.L.C. Teva Pharmaceutical Industries LTD Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 534,000 shares of TEVA stock, worth $10.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
534,000
Previous 484,000
10.33%
Holding current value
$10.7 Million
Previous $7.44 Million
20.3%
% of portfolio
0.02%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding TEVA
# of Institutions
652Shares Held
663MCall Options Held
30.1MPut Options Held
16.4M-
Black Rock Inc. New York, NY43MShares$863 Million0.02% of portfolio
-
Menora Mivtachim Holdings Ltd.38.5MShares$773 Million3.78% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.3MShares$770 Million36.86% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$759 Million5.98% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L337.8MShares$758 Million8.62% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $22.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...